日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel GPR120 agonist TUG891 modulates fat taste perception and preference and activates tongue-brain-gut axis in mice

新型 GPR120 激动剂 TUG891 可调节小鼠的脂肪味觉感知和偏好并激活舌-脑-肠轴

Babar Murtaza, Aziz Hichami, Amira S Khan, Bharat Shimpukade, Trond Ulven, Mehmet Hakan Ozdener, Naim A Khan

The GPR120 agonist TUG-891 promotes metabolic health by stimulating mitochondrial respiration in brown fat

GPR120 激动剂 TUG-891 通过刺激棕色脂肪中的线粒体呼吸来促进代谢健康

Maaike Schilperoort, Andrea D van Dam, Geerte Hoeke, Irina G Shabalina, Anthony Okolo, Aylin C Hanyaloglu, Lea H Dib, Isabel M Mol, Natarin Caengprasath, Yi-Wah Chan, Sami Damak, Anne Reifel Miller, Tamer Coskun, Bharat Shimpukade, Trond Ulven, Sander Kooijman, Patrick Cn Rensen, Mark Christian

The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120)

游离脂肪酸受体 4 (FFA4/GPR120) 配体相互作用的分子基础

Hudson, Brian D; Shimpukade, Bharat; Milligan, Graeme; Ulven, Trond

Concomitant action of structural elements and receptor phosphorylation determines arrestin-3 interaction with the free fatty acid receptor FFA4

结构元件和受体磷酸化的协同作用决定了阻遏蛋白-3与游离脂肪酸受体FFA4的相互作用。

Butcher, Adrian J; Hudson, Brian D; Shimpukade, Bharat; Alvarez-Curto, Elisa; Prihandoko, Rudi; Ulven, Trond; Milligan, Graeme; Tobin, Andrew B

The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism

TUG-891 是一种强效且选择性的游离脂肪酸受体 4 (FFA4/GPR120) 激动剂,其药理学研究既展现了治疗性激动剂作用的潜在机遇,也揭示了可能面临的挑战。

Hudson, Brian D; Shimpukade, Bharat; Mackenzie, Amanda E; Butcher, Adrian J; Pediani, John D; Christiansen, Elisabeth; Heathcote, Helen; Tobin, Andrew B; Ulven, Trond; Milligan, Graeme

Discovery of a potent and selective GPR120 agonist

发现有效且选择性的 GPR120 激动剂

Bharat Shimpukade, Brian D Hudson, Christine Kiel Hovgaard, Graeme Milligan, Trond Ulven